The Enterprise Value as of November 2024 (TTM) for Context Therapeutics Inc. (CNTX) is 68.71M

According to Context Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 68.71M. This represents a change of 1.65% compared to the average of 3.94M of the last 4 quarters.

Context Therapeutics Inc. (CNTX) Historical Enterprise Value (quarterly & annually)

How has CNTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Context Therapeutics Inc. over the last ten years is 22.08M. The current 68.71M Enterprise Value has changed 31.02% with respect to the historical average. Over the past ten years (40 quarters), CNTX's Enterprise Value was at its highest in in the December 2020 quarter at 57.68M. The Enterprise Value was at its lowest in in the December 2022 quarter at -25037290.26.

Context Therapeutics Inc. (CNTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Context Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Context Therapeutics Inc. (CNTX) Average Enterprise Value

How has CNTX Enterprise Value performed in the past?

The current Enterprise Value of Context Therapeutics Inc. (CNTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Context Therapeutics Inc. (CNTX) Enterprise Value vs. Peers

How is CNTX’s Enterprise Value compared to its peers?

Context Therapeutics Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (494.74M), less than Amylyx Pharmaceuticals, Inc. (312.13M), less than Acumen Pharmaceuticals, Inc. (131.19M), less than Inozyme Pharma, Inc. (305.00M), greater than X4 Pharmaceuticals, Inc. (18.46M), greater than Spero Therapeutics, Inc. (5.19M), greater than Bolt Biotherapeutics, Inc. (37.89M), less than Coherus BioSciences, Inc. (222.40M), less than Gracell Biotechnologies Inc. (5.49B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Day One Biopharmaceuticals, Inc. (865.54M), less than VectivBio Holding AG (848.58M), greater than NextCure, Inc. (22.52M), greater than CytomX Therapeutics, Inc. (50.52M), less than Assembly Biosciences, Inc. (89.71M), less than Zura Bio Limited (90.89M), less than Annexon, Inc. (642.06M), less than Icosavax, Inc. (713.87M), greater than IN8bio, Inc. (9.08M), less than Wave Life Sciences Ltd. (2.02B),

Build a custom stock screener for Context Therapeutics Inc. (CNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Context Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Context Therapeutics Inc. (CNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Context Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.